You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

LHRH Agonist

Showing 1 - 25 of 1,864
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,

Completed
Has Results
  • Prostate Adenocarcinoma
  • +4 more
  • Abiraterone Acetate
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Jul 14, 2022

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jun 5, 2023

Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • (no location specified)
Aug 10, 2022

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Breast Cancer Trial in Prato (Ribociclib, Aromatase Inhibitors, non steroideal, LHRH agonist)

Recruiting
  • Breast Cancer
  • Prato, Please Select:, Italy
    Hospital of Prato
Jul 27, 2022

Prostate Cancer Trial in Chicago (Patient Education)

Recruiting
  • Prostate Cancer
  • Patient Education
  • Chicago, Illinois
    University of Chicago Medicine Comprehensive Cancer Center
Feb 8, 2022

Prostatic Tumor Trial in Netherlands (Estetrol, Placebo Oral Tablet)

Completed
  • Prostatic Neoplasm
  • Arnhem, Gelderland, Netherlands
  • +5 more
Jun 16, 2021

Prostate Cancer Trial in France (Apalutamide, Salvage radiotherapy (SRT), Luteinising Hormone Releasing Hormone agonist (LHRHa))

Recruiting
  • Prostate Cancer
  • Albi, France
  • +14 more
Sep 22, 2021

Breast Cancer Trial in Worldwide (GDC-0810, LHRH Agonist, Palbociclib)

Terminated
Has Results
  • Breast Cancer
  • San Diego, California
  • +13 more
May 25, 2021

Prostatic Tumors Trial in Germany, Spain, United States (Abemaciclib, Darolutamide, LHRH agonist/antagonist)

Not yet recruiting
  • Prostatic Neoplasms
  • Mineola, New York
  • +14 more
Aug 23, 2023

Prostate Cancer Trial in London (Radiation, Androgen Suppression)

Completed
  • Prostate Cancer
  • Radiation
  • Androgen Suppression
  • London, Ontario, Canada
    London Regional Cancer Program of the Lawson Health Research Ins
Jun 1, 2021

Prostate Cancer Trial in Canada, United States (Prednisone, Apalutamide, Abiraterone Acetate)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +5 more
Jul 14, 2022

Prostate Cancer, Bone Metastases, Prostate Tumors Trial in United States (LHRH agonist/antagonist, Bicalutamide, Radium-223

Terminated
Has Results
  • Prostate Cancer
  • +2 more
  • LHRH agonist/antagonist
  • +2 more
  • Phoenix, Arizona
  • +11 more
Jul 7, 2022

Prostate Cancer Trial in Philadelphia (drug, radiation, genetic)

Active, not recruiting
  • Prostate Cancer
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Dec 7, 2020

Cancer of Prostate Trial in Belgium (Apalutamide, Leuprorelin Acetate 45Mg Powder for Injection Suspension Vial, Goserelin

Recruiting
  • Cancer of Prostate
  • Aalst, Belgium
  • +8 more
Aug 4, 2021

HER2-positive Breast Cancer, Invasive Carcinoma of the Breast, Breast Cancer Trial in United States (Pertuzumab+TRASTUZUMAB,

Recruiting
  • HER2-positive Breast Cancer
  • +5 more
  • Pertuzumab+TRASTUZUMAB
  • ADJUVANT ENDOCRINE THERAPY
  • Stamford, Connecticut
  • +21 more
Dec 12, 2022

Prostate Cancer Trial in Houston (Abiraterone Acetate, Prednisone, Enzalutamide)

Completed
Has Results
  • Prostate Cancer
  • Abiraterone Acetate
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Nov 19, 2019

Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Phesgo, Giredestrant, Docetaxel)

Recruiting
  • Locally Advanced or Metastatic Breast Cancer
  • Los Angeles, California
  • +21 more
Jul 25, 2022

Prostatic Tumors Trial in Worldwide (Radiotherapy, LHRHa, Apalutamide)

Recruiting
  • Prostatic Neoplasms
  • Radiotherapy
  • +2 more
  • Tucson, Arizona
  • +145 more
Jan 17, 2023

Prostate Cancer Trial in United States (ARN-509, LHRH Agonist)

Completed
Has Results
  • Prostate Cancer
  • Scottsdale, Arizona
  • +4 more
Feb 27, 2020

Melanoma Trial in Houston (Leuprolide, GP100: 209-217(210M) Peptide, MAGE-3 Peptide)

Completed
Has Results
  • Melanoma
  • Houston, Texas
    UT MD Anderson Cancer Center
Sep 27, 2019

Prostate Cancer Trial (iMAB, cMAB)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Jul 26, 2023

Prostate Cancer Trial in Chicago (Docetaxel, ADT, Abiraterone)

Not yet recruiting
  • Prostate Cancer
  • Chicago, Illinois
    Northwestern University
Sep 27, 2023